Cancer Biology & Medicine is a peer-reviewed english-language open-access journal published by China Anti-Cancer Association in China, operating under an open-access model since 2012. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Cancer Biology & Medicine; refer to the journal's APC page for the current rate. Articles are released under the CC BY-NC license (see other journals using this license).
Keywords
cancer genetics, oncology clinical trials, targeted therapy and immunology, cancer and stem cell biology, cancer prevention and epidemiology, cancer biomarkers
At a glance
- Publisher
- China Anti-Cancer Association
- Country
- China
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Peer review
- OA since
- 2012
- Review time
- 12 weeks
ISSN
- 2095-3941
Frequently asked questions
Is Cancer Biology & Medicine peer-reviewed?
Yes — Cancer Biology & Medicine operates a Peer review review process.
Does Cancer Biology & Medicine charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does Cancer Biology & Medicine publish?
Cancer Biology & Medicine publishes research in Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
What languages does Cancer Biology & Medicine accept?
Cancer Biology & Medicine accepts manuscripts in English.
What is the ISSN of Cancer Biology & Medicine?
ISSN:
2095-3941 (print).How do I submit a manuscript to Cancer Biology & Medicine?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Cancer Biology & Medicine?
Average time from submission to publication is approximately 12 weeks.